共 30 个 OTC 专论产品
| 序号 | NDC编码 | 商品名 | 剂型 | 上市日期 | 专论编号 |
|---|---|---|---|---|---|
| 1 | 57896-666-12 | ANTACID AND ANTIGAS | LIQUID | 2025-12-01 | M001 |
| 2 | 57896-662-12 | ANTACID AND ANTIGAS | LIQUID | 2025-12-01 | M001 |
| 3 | 57896-664-12 | MAXIMUM STRENGTH Antacid | SUSPENSION | 2024-05-01 | M001 |
| 4 | 57896-638-10 | GERI-MOX MAX CHERRY | SUSPENSION | 2000-01-01 | M001 |
| 5 | 57896-619-12 | GERI-LANTA MAXIMUM STRENGTH | SUSPENSION | 2000-01-01 | M001 |
| 6 | 57896-624-12 | GERI-LANTA SUPREME CHERRY | SUSPENSION | 2000-01-01 | M001 |
| 7 | 57896-629-12 | GERI-LANTA ANTACID ANTIGAS | SUSPENSION | 2000-01-01 | M001 |
| 8 | 57896-639-10 | GERI-MOX ANTACID ANTIGAS | SUSPENSION | 2000-01-01 | M001 |
| 9 | 57896-655-12 | ANTACID AND ANTIGAS | LIQUID | 2025-12-01 | M001 |
| 10 | 57896-004-12 | KO-LANTA | SUSPENSION | 2020-01-01 | M001 |
| 11 | 57896-791-01 | SIMETHICONE | TABLET, CHEWABLE | 2004-01-01 | M002 |
| 12 | 57896-798-01 | INFANTS GAS RELIEF | SUSPENSION | 2014-05-01 | M002 |
| 13 | 57896-694-03 | EXTRA STRENGTH GAS RELIEF | TABLET, CHEWABLE | 2020-03-01 | M002 |
| 14 | 57896-292-05 | EXTRA STRENGTH GAS RELIEF | CAPSULE, LIQUID FILLED | 2020-03-01 | M002 |
| 15 | 57896-143-14 | Triple Antibiotic | OINTMENT | 2022-04-01 | M004 |
| 16 | 57896-199-45 | TOLNAFTATE ANTIFUNGAL | POWDER | 2011-08-01 | M005 |
| 17 | 57896-421-01 | STOOL SOFTENER | TABLET | 2015-09-01 | M007 |
| 18 | 57896-647-12 | MILK OF MAGNESIA MINT | LIQUID | 2000-01-01 | M007 |
| 19 | 57896-648-12 | MILK OF MAGNESIA CHERRY | LIQUID | 2000-01-01 | M007 |
| 20 | 57896-649-10 | MILK OF MAGNESIA ORIGINAL | LIQUID | 2000-01-01 | M007 |
| 21 | 57896-266-10 | Magnesium Citrate | LIQUID | 2026-01-01 | M007 |
| 22 | 57896-661-08 | Geri-Tussin DM | LIQUID | 2019-05-01 | M012 |
| 23 | 57896-739-04 | GUAIASORB DM | LIQUID | 2023-03-31 | M012 |
| 24 | 57896-714-01 | MUCUS RELIEF | TABLET | 2021-02-01 | M012 |
| 25 | 57896-718-01 | MUCUS RELIEF | TABLET | 2026-08-01 | M012 |
| 26 | 57896-736-04 | Guaiasorb DM | LIQUID | 2019-10-01 | M012 |
| 27 | 57896-794-01 | MUCUS RELIEF | TABLET | 2004-01-01 | M012 |
| 28 | 57896-901-01 | Aspirin | TABLET | 1993-08-04 | M013 |
| 29 | 57896-131-01 | Dibucaine | OINTMENT | 2020-09-22 | M015 |
| 30 | 57896-181-05 | Artificial Tears | SOLUTION/ DROPS | 2018-06-01 | M018 |
标准化流程确保专论判定准确、文件齐备、标签合规,缩短整体办理周期。
提交配方表、活性成分、宣称用途及现有检测报告,进行初步合规评估。
比对21 CFR对应专论条款,确认产品归属类别及GRASE活性成分浓度范围。
指定美国代理人,完成FDA药品生产设施注册与产品列名申请。
按21 CFR 201.66制作Drug Facts标签,核对警示语、适应症与使用方法。
提供完整合规文件包,协助清关申报与上市后持续合规维护。
关于 OTC 化妆品出口美国合规的常见疑问解答。
微信号:KOL123567
添加时请备注「公司-职务-姓名」
优先安排资深法规专家 1 对 1 对接
我们已收到您的合规咨询需求
资深 FDA 法规顾问将在 1 个工作日内与您联系